Could a common blood pressure drug reveal Parkinson's secrets?
NCT ID NCT04386317
First seen Mar 28, 2026 · Last updated Jun 16, 2026 · Updated 14 times
Summary
This study looks at whether terazosin, a drug used for high blood pressure, can change heart nerve activity in people who may be in the early stages of Parkinson's disease. Researchers will study 15 adults aged 50-85 with REM sleep behavior disorder, a known risk factor for Parkinson's. The goal is to learn more about how Parkinson's develops, not to treat or cure it.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for REM SLEEP BEHAVIOR DISORDER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Michele L Lima Gregorio
Los Angeles, California, 90046, United States
Conditions
Explore the condition pages connected to this study.